Literature DB >> 10706100

EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface.

H Guo1, R Li, S Zucker, B P Toole.   

Abstract

Extracellular matrix metalloproteinase inducer (EMMPRIN), also known as basigin or CD147, is a glycoprotein that is enriched on the surface of tumor cells and stimulates production of several matrix metalloproteinases by adjacent stromal cells. In this study, we have found that EMMPRIN not only stimulates the production of interstitial collagenase (MMP-1) but also forms a complex with MMP-1 at the tumor cell surface. Complex formation was demonstrated by phage display, affinity chromatography, and immunocytochemistry. Presentation of MMP-1 complexed to EMMPRIN at the tumor cell surface may be important in modifying the tumor cell pericellular matrix to promote invasion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706100

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

Review 2.  Proteases at the endometrial-trophoblast interface: their role in implantation.

Authors:  Lois A Salamonsen; Guiying Nie
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

3.  Inhibitory effects of antisense RNA of HAb18G/CD147 on invasion of hepatocellular carcinoma cells in vitro.

Authors:  Yu Li; Peng Shang; Ai-Rong Qian; Li Wang; Yong Yang; Zhi-Nan Chen
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

4.  Acquisition of anoikis resistance through CD147 upregulation: A new mechanism underlying metastasis of hepatocellular carcinoma cells.

Authors:  Xia Ke; Ling Li; Hong-Lin Dong; Zhi-Nan Chen
Journal:  Oncol Lett       Date:  2012-03-27       Impact factor: 2.967

5.  Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration.

Authors:  Balachandar Venkatesan; Anthony J Valente; Venkatapuram Seenu Reddy; Deborah A Siwik; Bysani Chandrasekar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-26       Impact factor: 4.733

6.  Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma.

Authors:  Shaojun Zhu; Yanhong Li; Li Mi; Yang Zhang; Li Zhang; Li Gong; Xiujuan Han; Li Yao; Miao Lan; Zhinan Chen; Wei Zhang
Journal:  Dig Dis Sci       Date:  2011-07-26       Impact factor: 3.199

7.  Lack of evidence for caveolin-1 and CD147 interaction before and after bleomycin-induced lung injury.

Authors:  K Barth; R Bläsche; M Kasper
Journal:  Histochem Cell Biol       Date:  2006-05-30       Impact factor: 4.304

8.  Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance.

Authors:  Jian Gao; Zhenhua Hu; Juanjuan Liu; Dawo Liu; Yanyan Wang; Mingbo Cai; Danye Zhang; Mingzi Tan; Bei Lin
Journal:  Med Oncol       Date:  2014-04-02       Impact factor: 3.064

Review 9.  Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.

Authors:  V Yurchenko; S Constant; E Eisenmesser; M Bukrinsky
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

10.  Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma.

Authors:  Che Zhang; Ziliang Tu; Shiming Du; Yong Wang; Qibin Wang
Journal:  Pathol Oncol Res       Date:  2009-07-25       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.